Ibio Free Cash Flow Yield vs Operating Cash Flow Per Share Analysis

IBIO Stock

USD 2.94 0.31 11.79%

Ibio financial indicator trend analysis is infinitely more than just investigating Ibio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ibio Inc is a good investment. Please check the relationship between Ibio Free Cash Flow Yield and its Operating Cash Flow Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Free Cash Flow Yield vs Operating Cash Flow Per Share

Free Cash Flow Yield vs Operating Cash Flow Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ibio Inc Free Cash Flow Yield account and Operating Cash Flow Per Share. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Ibio's Free Cash Flow Yield and Operating Cash Flow Per Share is -0.05. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Operating Cash Flow Per Share in the same time period over historical financial statements of Ibio Inc, assuming nothing else is changed. The correlation between historical values of Ibio's Free Cash Flow Yield and Operating Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Ibio Inc are associated (or correlated) with its Operating Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Cash Flow Per Share has no effect on the direction of Free Cash Flow Yield i.e., Ibio's Free Cash Flow Yield and Operating Cash Flow Per Share go up and down completely randomly.

Correlation Coefficient

-0.05

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Most indicators from Ibio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ibio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At this time, Ibio's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 30th of November 2024, Enterprise Value Over EBITDA is likely to grow to 0.15, while Selling General Administrative is likely to drop about 11.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	2.2M	50K	225K	213.8K
Total Revenue	2.4M	50K	225K	213.8K

Gross Profit Total Revenue

Ibio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Total Equity	Inventory	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.44	0.44	0.95	0.83	-0.53	-0.4	0.47	0.91	0.87	0.94	0.88	-0.06	0.4	0.07	0.57	0.82	0.84	0.96	-0.22	0.61	0.69	0.52	-0.07	0.95	-0.74
Other Current Liab	0.44		0.79	0.42	0.2	-0.06	-0.71	0.44	0.21	0.35	0.26	0.34	0.19	-0.41	0.81	0.71	0.38	0.24	0.44	0.59	-0.05	0.28	0.7	0.55	0.38	-0.68
Total Current Liabilities	0.44	0.79		0.41	0.4	0.14	-0.56	0.7	0.1	0.54	0.17	0.51	0.01	-0.38	0.56	0.58	0.43	0.44	0.33	0.6	-0.23	0.43	0.56	0.31	0.36	-0.6
Total Stockholder Equity	0.95	0.42	0.41		0.67	-0.7	-0.4	0.49	0.92	0.73	0.96	0.9	0.0	0.31	0.02	0.58	0.64	0.68	0.97	-0.16	0.65	0.54	0.57	-0.04	0.99	-0.69
Property Plant And Equipment Net	0.83	0.2	0.4	0.67		-0.05	-0.21	0.4	0.64	0.97	0.65	0.68	-0.21	0.5	-0.08	0.33	0.94	0.99	0.65	-0.31	0.37	0.87	0.21	-0.27	0.68	-0.6
Net Debt	-0.53	-0.06	0.14	-0.7	-0.05		0.14	-0.14	-0.78	-0.1	-0.77	-0.59	-0.16	-0.21	0.21	-0.29	-0.03	-0.06	-0.72	0.24	-0.71	0.09	-0.39	0.0	-0.7	0.24
Retained Earnings	-0.4	-0.71	-0.56	-0.4	-0.21	0.14		-0.07	-0.25	-0.38	-0.26	-0.33	-0.73	0.32	-0.47	-0.98	-0.26	-0.3	-0.37	-0.56	0.2	-0.28	-0.91	-0.86	-0.3	0.86
Accounts Payable	0.47	0.44	0.7	0.49	0.4	-0.14	-0.07		0.28	0.46	0.34	0.62	-0.36	-0.23	0.15	0.16	0.37	0.4	0.42	0.16	0.14	0.33	0.18	-0.22	0.48	-0.24
Cash	0.91	0.21	0.1	0.92	0.64	-0.78	-0.25	0.28		0.64	0.99	0.81	-0.04	0.52	-0.1	0.43	0.64	0.63	0.96	-0.42	0.81	0.42	0.42	-0.14	0.93	-0.57
Non Current Assets Total	0.87	0.35	0.54	0.73	0.97	-0.1	-0.38	0.46	0.64		0.67	0.74	-0.07	0.34	0.0	0.49	0.9	0.99	0.7	-0.15	0.29	0.9	0.39	-0.1	0.73	-0.7
Cash And Short Term Investments	0.94	0.26	0.17	0.96	0.65	-0.77	-0.26	0.34	0.99	0.67		0.83	-0.04	0.47	-0.08	0.45	0.64	0.65	0.98	-0.37	0.79	0.49	0.45	-0.14	0.96	-0.58
Net Receivables	0.88	0.34	0.51	0.9	0.68	-0.59	-0.33	0.62	0.81	0.74	0.83		-0.07	0.21	-0.08	0.49	0.62	0.7	0.85	-0.1	0.51	0.45	0.5	-0.11	0.9	-0.63
Common Stock Shares Outstanding	-0.06	0.19	0.01	0.0	-0.21	-0.16	-0.73	-0.36	-0.04	-0.07	-0.04	-0.07		-0.43	-0.01	0.67	-0.29	-0.11	-0.04	0.46	-0.35	-0.03	0.68	0.87	-0.1	-0.38
Non Current Liabilities Total	0.4	-0.41	-0.38	0.31	0.5	-0.21	0.32	-0.23	0.52	0.34	0.47	0.21	-0.43		-0.27	-0.21	0.47	0.43	0.38	-0.79	0.67	0.28	-0.28	-0.58	0.37	-0.06
Other Current Assets	0.07	0.81	0.56	0.02	-0.08	0.21	-0.47	0.15	-0.1	0.0	-0.08	-0.08	-0.01	-0.27		0.4	0.2	-0.08	0.11	0.51	-0.15	-0.05	0.38	0.48	-0.01	-0.4
Other Stockholder Equity	0.57	0.71	0.58	0.58	0.33	-0.29	-0.98	0.16	0.43	0.49	0.45	0.49	0.67	-0.21	0.4		0.36	0.42	0.55	0.45	-0.03	0.37	0.94	0.76	0.49	-0.91
Total Liab	0.82	0.38	0.43	0.64	0.94	-0.03	-0.26	0.37	0.64	0.9	0.64	0.62	-0.29	0.47	0.2	0.36		0.91	0.68	-0.27	0.39	0.76	0.22	-0.19	0.66	-0.66
Property Plant And Equipment Gross	0.84	0.24	0.44	0.68	0.99	-0.06	-0.3	0.4	0.63	0.99	0.65	0.7	-0.11	0.43	-0.08	0.42	0.91		0.65	-0.26	0.31	0.88	0.3	-0.17	0.68	-0.65
Total Current Assets	0.96	0.44	0.33	0.97	0.65	-0.72	-0.37	0.42	0.96	0.7	0.98	0.85	-0.04	0.38	0.11	0.55	0.68	0.65		-0.24	0.73	0.49	0.54	-0.04	0.97	-0.68
Intangible Assets	-0.22	0.59	0.6	-0.16	-0.31	0.24	-0.56	0.16	-0.42	-0.15	-0.37	-0.1	0.46	-0.79	0.51	0.45	-0.27	-0.26	-0.24		-0.64	-0.14	0.52	0.7	-0.23	-0.22
Common Stock	0.61	-0.05	-0.23	0.65	0.37	-0.71	0.2	0.14	0.81	0.29	0.79	0.51	-0.35	0.67	-0.15	-0.03	0.39	0.31	0.73	-0.64		0.15	0.06	-0.45	0.69	-0.11
Property Plant Equipment	0.69	0.28	0.43	0.54	0.87	0.09	-0.28	0.33	0.42	0.9	0.49	0.45	-0.03	0.28	-0.05	0.37	0.76	0.88	0.49	-0.14	0.15		0.27	-0.11	0.53	-0.5
Common Stock Total Equity	0.52	0.7	0.56	0.57	0.21	-0.39	-0.91	0.18	0.42	0.39	0.45	0.5	0.68	-0.28	0.38	0.94	0.22	0.3	0.54	0.52	0.06	0.27		0.76	0.48	-0.78
Inventory	-0.07	0.55	0.31	-0.04	-0.27	0.0	-0.86	-0.22	-0.14	-0.1	-0.14	-0.11	0.87	-0.58	0.48	0.76	-0.19	-0.17	-0.04	0.7	-0.45	-0.11	0.76		-0.14	-0.51
Net Tangible Assets	0.95	0.38	0.36	0.99	0.68	-0.7	-0.3	0.48	0.93	0.73	0.96	0.9	-0.1	0.37	-0.01	0.49	0.66	0.68	0.97	-0.23	0.69	0.53	0.48	-0.14		-0.63
Retained Earnings Total Equity	-0.74	-0.68	-0.6	-0.69	-0.6	0.24	0.86	-0.24	-0.57	-0.7	-0.58	-0.63	-0.38	-0.06	-0.4	-0.91	-0.66	-0.65	-0.68	-0.22	-0.11	-0.5	-0.78	-0.51	-0.63

Click cells to compare fundamentals

Ibio Account Relationship Matchups

Ibio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	94.2M	147.0M	99.4M	41.2M	28.7M	38.8M
Other Current Liab	1.1M	3.3M	3.5M	5.9M	2.3M	1.9M
Total Current Liabilities	5.2M	6.6M	30.4M	21.6M	3.8M	6.2M
Total Stockholder Equity	56.6M	108.6M	63.5M	15.4M	21.3M	20.0M
Property Plant And Equipment Net	31.3M	34.7M	41.8M	7.6M	6.4M	6.1M
Net Debt	(22.2M)	(44.7M)	5.1M	12.8M	(9.8M)	(9.3M)
Retained Earnings	(150.4M)	(173.6M)	(223.9M)	(288.9M)	(313.8M)	(298.2M)
Accounts Payable	1.8M	2.3M	4.3M	1.8M	358K	340.1K
Cash	55.1M	77.4M	22.7M	4.3M	14.2M	15.5M
Non Current Assets Total	32.4M	42.4M	54.3M	14.9M	13.1M	17.9M
Cash And Short Term Investments	55.1M	97.0M	33.5M	4.3M	14.2M	17.3M
Net Receivables	5.6M	5.5M	6.1M	204K	713K	1.3M
Common Stock Shares Outstanding	125.6K	391.3K	436.1K	612.3K	3.8M	4.0M
Liabilities And Stockholders Equity	94.2M	147.0M	99.4M	41.2M	28.7M	38.8M
Non Current Liabilities Total	32.3M	31.8M	5.5M	4.2M	3.6M	3.4M
Other Current Assets	214K	2.1M	1.5M	21.8M	749K	711.6K
Other Stockholder Equity	206.9M	282.1M	287.6M	304.3M	335.2M	351.9M
Total Liab	37.6M	38.4M	35.9M	25.8M	7.4M	7.0M
Property Plant And Equipment Gross	31.3M	34.7M	45.3M	8.2M	7.9M	13.9M
Total Current Assets	61.7M	104.6M	45.1M	26.3M	15.7M	20.9M
Intangible Assets	1.1M	952K	4.9M	5.4M	5.4M	3.2M
Common Stock	16K	20K	140K	217K	9K	8.6K
Property Plant Equipment	3.7M	34.7M	41.8M	7.6M	8.7M	13.8M
Common Stock Total Equity	16K	20K	140K	217K	249.6K	262.0K
Inventory	798K	27K	3.9M	21.1M	24.3M	25.5M
Net Tangible Assets	56.6M	107.6M	58.6M	10.0M	11.5M	10.9M
Short Term Debt	562K	1.3M	22.3M	13.6M	953K	905.4K
Accumulated Other Comprehensive Income	(31K)	(33K)	(63K)	(213K)	(191.7K)	(182.1K)
Short Long Term Debt Total	32.9M	32.7M	27.8M	17.1M	4.5M	4.2M
Current Deferred Revenue	1.8M	423K	100K	4.2M	200K	190K
Capital Lease Obligations	32.3M	32.1M	5.6M	4.1M	3.5M	3.3M

Pair Trading with Ibio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ibio Stock

0.64	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.84	EWTX	Edgewise Therapeutics	Pair Corr
0.61	BHC	Bausch Health Companies	Pair Corr

Moving against Ibio Stock

0.71	ELAN	Elanco Animal Health	Pair Corr
0.61	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.54	HLN	Haleon plc	Pair Corr
0.54	TAK	Takeda Pharmaceutical	Pair Corr
0.38	RDY	Dr Reddys Laboratories	Pair Corr

The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.

The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:

How To Invest In Ibio

Details

Is Ibio Stock a good investment?

Details

What is Ibio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.03)

Revenue Per Share

0.059

Quarterly Revenue Growth

(0.88)

Return On Assets

(0.30)

Return On Equity

(0.84)

The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ibio Free Cash Flow Yield vs Operating Cash Flow Per Share Analysis

Free Cash Flow Yield vs Operating Cash Flow Per Share

Free Cash Flow Yield vs Operating Cash Flow Per Share Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Operating Cash Flow Per Share

Ibio fundamental ratios Correlations

Ibio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ibio fundamental ratios Accounts

Pair Trading with Ibio

Moving together with Ibio Stock

Moving against Ibio Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 0.99	Total Stockholder Equity
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Cash
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Current Assets	+ 0.97	Total Stockholder Equity

Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings Total Equity	- 0.91	Other Stockholder Equity
Common Stock Total Equity	- 0.91	Retained Earnings
Inventory	- 0.86	Retained Earnings
Intangible Assets	- 0.79	Non Current Liabilities Total
Retained Earnings Total Equity	- 0.78	Common Stock Total Equity